Endocrine Disruptors and Polycystic Ovary Syndrome (PCOS): Elevated Serum Levels of Bisphenol A in Women with PCOS

被引:342
作者
Kandaraki, Eleni [3 ]
Chatzigeorgiou, Antonis [2 ]
Livadas, Sarantis [1 ]
Palioura, Eleni [1 ]
Economou, Frangiscos
Koutsilieris, Michael [2 ]
Palimeri, Sotiria [1 ]
Panidis, Dimitrios [4 ]
Diamanti-Kandarakis, Evanthia [1 ]
机构
[1] Univ Athens, Sch Med, Dept Internal Med 3, Endocrine Unit, Athens 11854, Greece
[2] Univ Athens, Sch Med, Dept Expt Physiol, Athens 11854, Greece
[3] Huddersfield Royal Infirm Hosp, Dept Med, Huddersfield HD3 3EA, W Yorkshire, England
[4] Aristotle Univ Thessaloniki, Dept Obstet & Gynecol 2, Div Endocrinol & Human Reprod, Thessaloniki 54636, Greece
关键词
NEONATAL EXPOSURE; ANDROGEN; CELLS;
D O I
10.1210/jc.2010-1658
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Context: Bisphenol A (BPA) is a widespread industrial compound used in the synthesis of polycarbonate plastics. In experimental animals, neonatal exposure to BPA results in a polycystic ovary-like syndrome (PCOS) in adulthood. A bidirectional interaction between androgens and BPA levels has been disclosed. Objective: To determine BPA levels in PCOS women as well as the association between BPA and hormonal/metabolic parameters compared to a control group. Design, Setting, and Participants: Cross-sectional study of 71 PCOS (National Institutes of Health criteria) and 100 normal women, age-and body mass index-matched, in a University hospital setting. Main Outcome Measures: Anthropometric, hormonal, metabolic parameters and BPA blood levels were determined. Patients (PCOS) and controls (C) were further subdivided according to body mass index into lean and overweight subgroups, respectively. Results: BPA levels were significantly higher in the total PCOS group compared with the controls (1.05 +/- 0.56 vs. 0.72 +/- 0.37ng/ml, P < 0.001). PCOS women, lean (PCOS-L) and overweight (PCOS-OW), had higher BPA levels compared to the corresponding control group lean (C-L) and overweight (C-OW): (PCOS-L = 1.13 +/- 0.63 vs. C-L = 0.70 +/- 0.36, P < 0.001) (PCOS-OW = 0.96 +/- 0.46 vs. C-OW = 0.72 +/- 0.39, P < 0.05). A significant association of testosterone (r = 0.192, P < 0.05) and androstenedione (r = 0.257, P < 0.05) with BPA was observed. Multiple regression analysis for BPA showed significant correlation with the existence of PCOS (r = 0.497, P < 0.05). BPA was also positively correlated with insulin resistance (Matsuda index) in the PCOS group (r = 0.273, P < 0.05). Conclusions: Higher BPA levels in PCOS women compared to controls and a statistically significant positive association between androgens and BPA point to a potential role of this endocrine disruptor in PCOS pathophysiology. (J Clin Endocrinol Metab 96: E480-E484, 2011)
引用
收藏
页码:E480 / E484
页数:5
相关论文
共 27 条
[1]
Alexandraki Krystallenia, 2006, Hormones (Athens), V5, P126
[2]
Screening and testing for endocrine disruption in fish - Biomarkers as "signposts," not "traffic lights," in risk assessment [J].
Hutchinson, Thomas H. ;
Ankley, Gerald T. ;
Segner, Helmut ;
Tyler, Charles R. .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2006, 114 :106-114
[3]
Low doses of bisphenol A and diethylstilbestrol impair Ca2+ signals in pancreatic α-cells through a nonclassical membrane estrogen receptor within intact islets of Langerhans [J].
Alonso-Magdalena, P ;
Laribi, O ;
Ropero, AB ;
Fuentes, E ;
Ripoll, C ;
Soria, B ;
Nadal, A .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2005, 113 (08) :969-977
[4]
Determination of bisphenol-A in reusable polycarbonate food-contact plastics and migration to food-simulating liquids [J].
Biles, JE ;
McNeal, TP ;
Begley, TH ;
Hollifield, HC .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 1997, 45 (09) :3541-3544
[5]
Toxicology: The big test for bisphenol A [J].
Borrell, Brendan .
NATURE, 2010, 464 (7292) :1122-1124
[6]
Xenoestrogen interaction with human sex hormone-binding globulin (hSHBG) [J].
Déchaud, H ;
Ravard, C ;
Claustrat, F ;
de la Perrière, AB ;
Pugeat, M .
STEROIDS, 1999, 64 (05) :328-334
[7]
The Impact of Endocrine Disruptors on Endocrine Targets [J].
Diamanti-Kandarakis, E. ;
Palioura, E. ;
Kandarakis, S. A. ;
Koutsilieris, M. .
HORMONE AND METABOLIC RESEARCH, 2010, 42 (08) :543-552
[8]
A survey of the polycystic ovary syndrome in the Greek island of Lesbos: Hormonal and metabolic profile [J].
Diamanti-Kandarakis, E ;
Kouli, CR ;
Bergiele, AT ;
Filandra, FA ;
Tsianateli, TC ;
Spina, GG ;
Zapanti, ED ;
Bartzis, MI .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (11) :4006-4011
[9]
Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS) [J].
Diamanti-Kandarakis, Evanthia ;
Katsikis, Ilias ;
Piperi, Christina ;
Kandaraki, Eleni ;
Piouka, Athanasia ;
Papavassiliou, Athanasios G. ;
Panidis, Dimitrios .
CLINICAL ENDOCRINOLOGY, 2008, 69 (04) :634-641
[10]
Diamanti-Kandarakis Evanthia, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000598